NCT06814327

Brief Summary

During this observational study, the investigators aim to assess the ability of ICU clinicians to predict the risk of impending organ failure and retrospectively compare it to the performance of previously published machine learning models. The central hypothesis of this study is that the treating physician can predict impending organ failure in adult ICU patients with similar accuracy as the best previously publishes machine learning models.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
499

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Nov 2024May 2026

First Submitted

Initial submission to the registry

November 18, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

November 18, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Expected
Last Updated

August 28, 2025

Status Verified

November 1, 2024

Enrollment Period

6 months

First QC Date

November 18, 2024

Last Update Submit

August 27, 2025

Conditions

Keywords

Machine learningIntensive careartificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Clinician prediction of circulatory failure within 8 hours compared to published ML models

    This outcome compares the area under the receiver operating characteristic curve (auROC) for two methods of predicting circulatory failure within 8 hours of each assessment time point: (1) ICU clinicians' risk estimates, and (2) previously published machine learning (ML) models applied retrospectively. For each assessment, we compute the auROC separately for clinicians and for the ML model for the same time points and patients. The difference in auROC (clinician minus ML) is the main measure of interest, evaluated under a non-inferiority framework with a margin of 0.025.

    Assessments are collected within the first 72 hours following admission.

Secondary Outcomes (1)

  • Clinician prediction of respiratory failure within 24 hours compared to published ML models

    Assessments are collected within the first 72 hours following admission.

Other Outcomes (6)

  • Exploratory analysis of clinician prediction of renal failure within 48 hours compared to published ML models

    Assessments are collected within the first 72 hours following admission.

  • Exploratory analysis of clinician mortality prediction compared to published ML models

    Assessments are collected within the first 72 hours following admission.

  • Exploratory analysis of predictive accuracy of treating physicians versus treating nurses

    Assessments are collected within the first 72 hours following admission.

  • +3 more other outcomes

Study Arms (1)

Adult ICU patients

Adult ICU patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult Intensive Care Unit at the University Hospital Bern

You may qualify if:

  • patient minimum age of 18 years
  • emergency admission to the ICU
  • arterial line in place

You may not qualify if:

  • documented refusal (on the general consent form) to participate to clinical research
  • patients with neurologic conditions that impair the patient's level of consciousness (including, but not limited to stroke, traumatic brain injury, intracranial hemorrhage, CNS infections; except polytrauma)
  • patients on mechanical circulatory support systems (IABP, VA-ECMO, Impella, VAD) or extracorporeal membrane oxygenation (VV-ECMO) at any time during their ICU stay;
  • patients receiving end-of-life care or are admitted for the sole purpose of evaluating organ donation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Inselspital, Berne

Bern, Canton of Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

ShockRespiratory InsufficiencyRenal Insufficiency

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Martin Faltys, Dr. med.

    Insel Gruppe AG, University Hospital Bern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2024

First Posted

February 7, 2025

Study Start

November 18, 2024

Primary Completion

May 15, 2025

Study Completion (Estimated)

May 15, 2026

Last Updated

August 28, 2025

Record last verified: 2024-11

Locations